Dai L, Hou J, Cai H
Drum Tower Hospital, Nanjing.
Zhonghua Jie He He Hu Xi Za Zhi. 1996 Feb;19(1):26-8.
To seek a kind of Chinese traditional medicine to treat the bleomycin-induced pulmonary fibrosis.
SD rats with bleomycin A(s) induced pulmonary fibrosis, were divided into 4 groups. Normal control group (10 rats), untreated model group (35 rats), ligustrazini group (10 rats), Angelica sinensis group (10 rats). Both ligustrazini and angelica sinensis were given intraperitoneally by injection daily for 28 days. Then all rats were put to death and took out the lungs for examination. Using histopathological examination and image processing computer assisted to evaluate the result of treatments.
Ligustrazini could obviously reduced alveolitis and fibrosis and Angelica sinensis had the similar but lesser result.
Ligustrazini and angelica sinensis have successful result of treatment for pulmonary fibrosis.
寻找一种治疗博莱霉素诱导的肺纤维化的中药。
将博莱霉素A诱导的肺纤维化SD大鼠分为4组。正常对照组(10只大鼠)、未治疗模型组(35只大鼠)、川芎嗪组(10只大鼠)、当归组(10只大鼠)。川芎嗪和当归均每日腹腔注射给药,持续28天。然后处死所有大鼠,取出肺进行检查。采用组织病理学检查和计算机图像处理辅助评估治疗结果。
川芎嗪可明显减轻肺泡炎和纤维化,当归有类似但较弱的效果。
川芎嗪和当归治疗肺纤维化取得成功。